Answer
In patients receiving gilteritinib fumarate, posterior reversible encephalopathy syndrome can cause rapidly evolving seizures, headache, confusion, visual and neurological disturbances, with or without associated hypertension and altered mental status.
Sources for this answer
- Gilteritinib Astellas 40 mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked